Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074-Reference-Cited by-同舟云学术

Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074

Published:2004-03-18 Issue:5 Volume:18 Page:962-966
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Grand E K,Chase A J,Heath C,Rahemtulla A,Cross N C P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2403347.pdf

Reference21 articles.

1. Chesi M, Nardin, E, Brents LA, Schrock E, Ried T, Kuehl WM et al. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997; 16: 260–264.

2. Giri D, Ropiquet F, Ittmann M . Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 199; 5: 1063–1071.

3. Onose H, Emoto N, Sugihara H, Shimizu K, Wakabayashi I . Overexpression of fibroblast growth factor receptor 3 in a human thyroid carcinoma cell line results in overgrowth of the confluent cultures. Eur J Endocrinol 1999; 140: 169–173.

4. Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M et al. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR1) in human breast cancer. Clin Immunol Immunopathol 1998; 89: 28–34.

5. Wagner M, Lopez ME, Cahn M, Korc M . Suppression of fibroblast growth factor receptor signalling inhibits pancreatic cancer growth in vitro and in vivo. Gastroenterology 1998; 114: 798–807.

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR and inhibitors;Fibroblast Growth Factors;2024

2. The role of fibroblast growth factor 18 in cancers: functions and signaling pathways;Frontiers in Oncology;2023-05-09

3. A Comprehensive Analysis of the PI3K/AKT Pathway: Unveiling Key Proteins and Therapeutic Targets for Cancer Treatment;Cancer Informatics;2023-01

4. PEMT: a patent enrichment tool for drug discovery;Bioinformatics;2022-11-02

5. PEMT: A patent enrichment tool for drug discovery;2022-08-01